Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gemcitabine, Trastuzumab, and Cisplatin in Metastatic Breast Cancer
NCT00201760Phase 2Completed
- Sponsor
- Kari Kendra
- Start
- Feb 2005
- Primary completion
- Oct 2009
- Modality
- Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Cisplatin micelle injection (HA132) in breast cancer, sponsored by Kari Kendra. Started Feb 2005; status: completed.
02
Drugs
Cisplatin micelle injection (HA132)
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00201760.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00201760.